Skip to main content
. 2015 Nov 30;10(4):610–624. doi: 10.1016/j.molonc.2015.11.010

Figure 6.

Figure 6

Clinical data analysis for hnRNPA2/B1 and COX‐2 in human tissue microarrays from NSCLC patients. (A) Expression of hnRNPA2/B1 and COX‐2 in tumor tissues from NSCLC patients detected by immunohistochemical staining. (B) Expression of hnRNPA2/B1 in tumor tissues and their adjacent non‐malignant lung tissues from NSCLC patients. (C) Clinical prognosis factors and clinicopathologic characteristics of 75 NSCLC patients.